Abstract | OBJECTIVES: METHODS: Biodegradable microspheres made of end-group capped and uncapped poly(lactide-co-glycolide) 50:50 (PLGA 50:50 and PLGA 50:50H) and containing gentamicin sulphate were used to target Brucella abortus-infected J774 monocyte-macrophages. The infected cells were treated with 15 micro g of free or microencapsulated gentamicin and the efficacy of the treatments was measured after 24 h. RESULTS: The particle sizes were below 8 micro m and in vitro release of gentamicin from the microspheres followed a continuous (PLGA 50:50H) or a multiphasic (PLGA 50:50) pattern over 50 days. Treatment with gentamicin microencapsulated into the end-group uncapped PLGA 50:50H microspheres, decreased significantly the number of intracellular bacteria (typically by 2 log(10)) in comparison with untreated infected cells. Addition of 2% poloxamer 188 to the microsphere dispersion medium further reduced the infection (3.5 log(10)). Opsonization of the particles with non-immune mouse serum had no effect on the antibacterial efficacy of the microspheres. End-group capped PLGA 50:50 type microspheres containing the antibiotic were less effective at reducing intracellular bacteria ( approximately 1 log(10) reduction), although addition of poloxamer 188 to the dispersion medium again enhanced their intracellular antibacterial activity. Placebo PLGA 50:50 and PLGA 50:50H microspheres had no bactericidal activity. CONCLUSIONS: The results indicate that PLGA 50:50-microencapsulated gentamicin sulphate may be suitable for efficient drug targeting and delivery to reduce intracellular Brucella infections.
|
Authors | Sandra Prior, Bruno Gander, Concepción Lecároz, Juan M Irache, Carlos Gamazo |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 53
Issue 6
Pg. 981-8
(Jun 2004)
ISSN: 0305-7453 [Print] England |
PMID | 15102748
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Gentamicins
- Polymers
- Polylactic Acid-Polyglycolic Acid Copolymer
- Polyglycolic Acid
- Lactic Acid
|
Topics |
- Animals
- Anti-Bacterial Agents
(administration & dosage, pharmacology)
- Brucella abortus
(drug effects)
- Brucellosis
(microbiology)
- Cell Line
- Drug Compounding
- Gentamicins
(administration & dosage, pharmacology)
- Lactic Acid
- Mice
- Microspheres
- Monocytes
(drug effects, microbiology)
- Particle Size
- Phagocytosis
- Polyglycolic Acid
- Polylactic Acid-Polyglycolic Acid Copolymer
- Polymers
- Respiratory Burst
(drug effects)
|